Logo En IconLogo Mark IconIcelandic Intellectual Property Office

SPC317

Indakaterólasetat eða indakaterólxínalóat í samsetningu með mómetasónfúróati, ákjósanlega indakaterólasetat í samsetningu með mókmetasónfúróati

  • Status:
    Umsókn
  • Application date:
    10.11.2020
  • Application published:
    15.12.2020
  • Max expiry date:
    1.7.2032
  • Medicine name:
    Atectura Breezhaler og Bremerist Breezhaler
  • Medicine for children:
    No

Timeline

Today
10.11.2020Application
15.12.2020Publication
1.7.2032Expires

Marketing license

  • IS authorization number:
    EU/1/20/1439/001-004, EU/1/20/1439/005-008, EU/1/20/1439/009-012 & EU/1/20/1441/001-004, EU1/20/1551/005-008, EU/1/20/1441/009-012
  • Date:
    23.6.2020
  • Foreign authorization number:
    EU/1/20/1439 & EU/1/20/1441
  • Date:
    30.5.2020

Owner

  • Name:
    Novartis AG
  • Address:
    Lichtstrasse 35, Basel CH

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents